{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:05:02Z","timestamp":1779858302984,"version":"3.53.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xphs.2025.103954","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:11:10Z","timestamp":1755097870000},"page":"103954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel cyclophosphamide microemulsion exhibits enhanced efficacy: Formulation development, evaluation, in-vitro cytotoxicity and in-vivo efficacy studies"],"prefix":"10.1016","volume":"114","author":[{"given":"Ankit K.","family":"Vankani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krutika K.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1130","key":"10.1016\/j.xphs.2025.103954_bib0001","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103954_bib0002","doi-asserted-by":"crossref","DOI":"10.55920\/2771-019X\/1305","article-title":"Overview of cancers","volume":"2","author":"Ibrahim","year":"2022","journal-title":"J Clin Med Images Case Rep"},{"key":"10.1016\/j.xphs.2025.103954_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"issue":"S10","key":"10.1016\/j.xphs.2025.103954_bib0004","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/cncr.32857","volume":"126","author":"Stoltenberg","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.xphs.2025.103954_bib0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5306\/wjco.v5.i3.283","article-title":"Pathogenesis, prevention, diagnosis and treatment of breast cancer","volume":"5","author":"Shah","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.xphs.2025.103954_bib0006","author":"Coleman"},{"key":"10.1016\/j.xphs.2025.103954_bib0007","article-title":"0528 poster session breast cancer: global patterns of incidence","author":"Sedeta","year":"2023","journal-title":"Mortal Trends"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0008","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ajco.12661","article-title":"Epidemiology of breast cancer in Indian women","volume":"13","author":"Malvia","year":"2017","journal-title":"Asia-Pac J Clin Oncol"},{"key":"10.1016\/j.xphs.2025.103954_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/137414","article-title":"Drug resistance and the role of combination chemotherapy in improving patient outcomes","volume":"2013","author":"Yardley","year":"2013","journal-title":"Int J Breast Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010006","article-title":"Co-delivery of letrozole and cyclophosphamide via folic acid-decorated nanoniosomes for breast cancer therapy: synergic effect, augmentation of cytotoxicity, and apoptosis gene expression","volume":"15","author":"Sahrayi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.xphs.2025.103954_bib0011","unstructured":"Knyazev EN, Nikulin S v, Khristichenko AY, et al. Ul. Sukhanova, 690091 Vladivostok, Russian Federation d D. Rogachev federal scientifi c and clinical center for pediatric hematology, oncology, and immunology, 1 Ul. Samory Machela, 117997 Moscow, Russian Federation e institute of nanotechnology of microelectronics, Russian academy of sciences, 32A Leninsky Prosp., 119991 Moscow. vol 68.; 2019."},{"issue":"21","key":"10.1016\/j.xphs.2025.103954_bib0012","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1021\/la300691n","article-title":"Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells","volume":"28","author":"Gulfam","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.xphs.2025.103954_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/358782","article-title":"Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity","volume":"2012","author":"Emami","year":"2012","journal-title":"J Nanomater"},{"key":"10.1016\/j.xphs.2025.103954_bib0014","unstructured":"Beijnen JH, van Gijn R, Challa EE, et al. Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids LinkOut-more resources other literature sources the lens-patent citations database medical medlineplus health information."},{"issue":"3","key":"10.1016\/j.xphs.2025.103954_bib0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.xphs.2018.10.020","article-title":"Crystallization of cyclophosphamide monohydrate during lyophilization","volume":"108","author":"Munjal","year":"2019","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/scipharm88040042","article-title":"The mechanism of action of cyclophosphamide and its consequences for the development of a new generation of oxazaphosphorine cytostatics","volume":"88","author":"Voelcker","year":"2020","journal-title":"Sci Pharm"},{"key":"10.1016\/j.xphs.2025.103954_bib0017","author":"Brooke"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3816\/CBC.2005.n.017","article-title":"Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer","volume":"6","author":"Overmoyer","year":"2005","journal-title":"Clin Breast Cancer"},{"issue":"18","key":"10.1016\/j.xphs.2025.103954_bib0019","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol Biol Cell"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jhet.5570100113","article-title":"Studies on the hydrolysis of cyclophosphamide II. Isolation and characterization of intermediate hydrolytic products","volume":"10","author":"Chakrabarli","year":"1973","journal-title":"J Heterocycl Chem"},{"issue":"23","key":"10.1016\/j.xphs.2025.103954_bib0021","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1021\/jm00049a018","article-title":"Chemical and biological evaluation of hydrolysis products of cyclophosphamide","volume":"37","author":"Gilard","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.xphs.2025.103954_bib0022","unstructured":"To\u0144ski M, Do\u0142\u017conek J, Stepnowski P, Bia\u0142k-Bieli\u0144ska A. Hydrolytic stability of anticancer drugs and one metabolite in the aquatic environment. doi:10.1007\/s11356-021-14360-0\/Published."},{"issue":"3","key":"10.1016\/j.xphs.2025.103954_bib0023","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/187221108786241679","article-title":"Microemulsions: a novel approach to enhanced drug delivery","volume":"2","author":"Talegaonkar","year":"2008","journal-title":"Recent Pat Drug Deliv Formul"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0024","first-page":"77","article-title":"Improved drug delivery using microemulsions: rationale, recent progress, and new horizons","volume":"18","author":"Bagwe","year":"2001","journal-title":"Crit Rev Ther Drug Carr Syst"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103954_bib0026","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: implications for multi-drug delivery","volume":"526","author":"Callender","year":"2017","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0027","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/17425247.2014.870151","article-title":"Controlled-release injectable microemulsions: recent advances and potential opportunities","volume":"11","author":"Dubey","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"16","key":"10.1016\/j.xphs.2025.103954_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/nano13162311","article-title":"Microemulsions of nonionic surfactant with water and various homologous esters: preparation, phase transitions, physical property measurements, and application for extraction of tricyclic antidepressant drugs from aqueous media","volume":"13","author":"Racovita","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.xphs.2025.103954_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125387","article-title":"Nutraceutical formulated oil-in-water emulsion: synthesis, characterization and biological applications","volume":"408","author":"Khan","year":"2024","journal-title":"J Mol Liq"},{"issue":"23","key":"10.1016\/j.xphs.2025.103954_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/en14237981","article-title":"Formulation and study of an environmentally friendly microemulsion-based drilling fluid (O\/w) with pine oil","volume":"14","author":"de Sousa","year":"2021","journal-title":"Energies"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0031","first-page":"867","article-title":"Development and characterization of biocompatible isotropic and anisotropic oil-in-water colloidal dispersions as a new delivery system for methyl dihydrojasmonate antitumor drug","volume":"9","author":"da Silva","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2025.103954_bib0032","series-title":"Materials Science Forum. Vol 1001 MSF","first-page":"110","article-title":"Preparation and research of oil in water microemulsion","author":"Chen","year":"2020"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15422119.2018.1524386","article-title":"Oil-in-water microemulsion liquid chromatography","volume":"49","author":"Peris-Garc\u00eda","year":"2020","journal-title":"Sep Purif Rev"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0034","doi-asserted-by":"crossref","DOI":"10.1111\/jfpe.13032","article-title":"Preparation and characterization of water in sesame oil microemulsion by spontaneous method","volume":"42","author":"Nazari","year":"2019","journal-title":"J Food Process Eng"},{"key":"10.1016\/j.xphs.2025.103954_bib0035","unstructured":"Setiati R, Fathaddin MT, Fatahanissa A. The importance of microemulsion for the surfactant injection process in enhanced oil recovery. www.intechopen.com."},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0036","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10717540601067760","article-title":"Controlled release of methotrexate from W\/O microemulsion and its in vitro antitumor activity","volume":"14","author":"Karasulu","year":"2007","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0037","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/17425241003596337","article-title":"Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs","volume":"7","author":"He","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0038","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/17425247.5.1.119","article-title":"Microemulsions as novel drug carriers: the formation, stability, applications and toxicity","volume":"5","author":"Karasulu","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0039","doi-asserted-by":"crossref","first-page":"008","DOI":"10.17352\/ijpsdr.000003","article-title":"Advancements in microemulsion based drug delivery systems for better therapeutic effects","volume":"1","author":"Sahu","year":"2015","journal-title":"Int J Pharm Sci Dev Res"},{"key":"10.1016\/j.xphs.2025.103954_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cis.2006.11.016","article-title":"Microemulsions as carriers for drugs and nutraceuticals","volume":"128-130","author":"Spernath","year":"2006","journal-title":"Adv Colloid Interface Sci"},{"issue":"5","key":"10.1016\/j.xphs.2025.103954_bib0041","doi-asserted-by":"crossref","first-page":"138","DOI":"10.22159\/ijap.2018v10i5.27415","article-title":"Preparation and evaluation of microemulsion containing antihypertensive drug","volume":"10","author":"Yadav","year":"2018","journal-title":"Int J Appl Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0042","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/156720106776359168","article-title":"Microemulsions: a potential drug delivery system","volume":"3","author":"Ghosh","year":"2006","journal-title":"Curr Drug Deliv"},{"issue":"11","key":"10.1016\/j.xphs.2025.103954_bib0043","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3109\/03639049809089948","article-title":"The composition of NF-defined emulsifiers: sorbitan monolaurate, monopalmitate, monostearate, monooleate, polysorbate 20, polysorbate 40, polysorbate 60, and polysorbate 80","volume":"24","author":"Brandner","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/03639045.2017.1386202","article-title":"Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids","volume":"44","author":"Shah","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13197-017-2937-5","article-title":"Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification","volume":"55","author":"Akhoond Zardini","year":"2018","journal-title":"J Food Sci Technol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0046","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12247-020-09488-4","article-title":"Surface tension and self-association properties of aqueous polysorbate 20 HP and 80 HP solutions: insights into protein stabilisation mechanisms","volume":"16","author":"Garidel","year":"2021","journal-title":"J Pharm Innov"},{"issue":"56","key":"10.1016\/j.xphs.2025.103954_bib0047","doi-asserted-by":"crossref","first-page":"35086","DOI":"10.1039\/C7RA06119F","article-title":"Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer","volume":"7","author":"Ding","year":"2017","journal-title":"RSC Adv"},{"issue":"9","key":"10.1016\/j.xphs.2025.103954_bib0048","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1248\/cpb.c15-00378","article-title":"Microemulsion using polyoxyethylene sorbitan trioleate and its usage for skin delivery of resveratrol to protect skin against UV-induced damage","volume":"63","author":"Yutani","year":"2015","journal-title":"Chem Pharm Bull"},{"issue":"7","key":"10.1016\/j.xphs.2025.103954_bib0049","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s11094-022-02735-7","article-title":"Using polysorbates to create parenteral dosage forms of hydrophobic substances (a review)","volume":"56","author":"Sanarova","year":"2022","journal-title":"Pharm Chem J"},{"issue":"9","key":"10.1016\/j.xphs.2025.103954_bib0050","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1023\/B:PHAM.0000041451.70367.21","article-title":"Design and evaluation of an emulsion vehicle for Paclitaxel. I. Physicochemical properties and plasma stability","volume":"21","author":"Han","year":"2004","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0051","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5530\/ijper.50.2.8","article-title":"Soluplus based polymeric micelles and mixed micelles of lornoxicam: design, characterization and in vivo efficacy studies in rats","volume":"50","author":"Bhuptani","year":"2016","journal-title":"Indian J Pharm Educ Res"},{"issue":"5","key":"10.1016\/j.xphs.2025.103954_bib0052","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.apsb.2018.07.011","article-title":"Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications","volume":"8","author":"Ahire","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2025.103954_bib0053","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.biopha.2014.12.028","article-title":"Soluplus\u00ae micelles as a potential drug delivery system for reversal of resistant tumor","volume":"69","author":"Jin","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2025.103954_bib0054","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcis.2021.12.016","article-title":"Understanding the self-assembly of the polymeric drug solubilizer Soluplus\u00ae","volume":"611","author":"Mateos","year":"2022","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.xphs.2025.103954_bib0055","article-title":"Soluplus\u00ae as a solubilizing excipient for poorly water-soluble drugs: recent advances in formulation strategies and pharmaceutical product features","volume":"84","author":"Attia","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2025.103954_bib0056","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/2468187309666190314152451","article-title":"Polymeric nanomicelles of Soluplus\u00ae as a strategy for enhancing the solubility, bioavailability and efficacy of poorly soluble active compounds","volume":"9","author":"Pignatello","year":"2019","journal-title":"Curr Nanomed"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0057","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfa.2014.04.032","article-title":"Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug","volume":"455","author":"Chen","year":"2014","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.xphs.2025.103954_bib0058","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejps.2015.10.015","article-title":"Use of solubilizers in preclinical formulations: effect of Cremophor EL on the pharmacokinetic properties on early discovery compounds","volume":"87","author":"Liu","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103954_bib0059","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.colsurfb.2019.04.058","article-title":"Effects of cremophor EL\/ethanol\/oleinic acid\/water microemulsion on human blood components and coagulation function","volume":"180","author":"Zhang","year":"2019","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2025.103954_bib0060","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.2147\/IJN.S105419","article-title":"Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique","volume":"11","author":"Li","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2025.103954_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.118425","article-title":"Structure and pseudo-ternary phase diagram of water\/triton X-100\/1-pentanol\/cyclohexane microemulsion","volume":"349","author":"Liu","year":"2022","journal-title":"J Mol Liq"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0062","doi-asserted-by":"crossref","first-page":"42","DOI":"10.26650\/IstanbulJPharm.2020.0090","article-title":"Pseudo ternary phase diagrams: a practical approach for the area and centroid calculation of stable microemulsion regions","volume":"51","author":"Berkman","year":"2021","journal-title":"\u0130stanb J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0063","article-title":"Preparation and characterization of functional compounds encapsulated microemulsion with nonionic surfactants","volume":"20","author":"Zhong","year":"2020","journal-title":"J Food Drug Anal"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0064","doi-asserted-by":"crossref","first-page":"151","DOI":"10.55747\/bjedis.v1i2.48370","article-title":"Surface modeling as a tool for constructing pseudo ternary diagrams","volume":"1","author":"Camilo","year":"2021","journal-title":"Braz J Exp Des Data Anal Inferent Stat"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11743-015-1694-6","article-title":"The Schulman method of cosurfactant titration of the oil\/water interface (dilution method): a review on a well-known powerful technique in interfacial science for characterization of water-in-oil microemulsions","volume":"18","author":"Bardhan","year":"2015","journal-title":"J Surfactants Deterg"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0066","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tca.2006.02.017","article-title":"Construction of solid-liquid phase diagrams in ternary systems by titration calorimetry","volume":"445","author":"Hamedi","year":"2006","journal-title":"Thermochim Acta"},{"issue":"3","key":"10.1016\/j.xphs.2025.103954_bib0067","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/0250-474X.159596","article-title":"Role of components in the formation of self-microemulsifying drug delivery systems","volume":"77","author":"Gurram","year":"2015","journal-title":"Indian J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0068","first-page":"141","article-title":"Preparation and evaluation of tretinoin microemulsion based on pseudo-ternary phase diagram","volume":"2","author":"Moghimipour","year":"2012","journal-title":"Adv Pharm Bull"},{"issue":"7","key":"10.1016\/j.xphs.2025.103954_bib0069","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1008211629858","article-title":"Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer","volume":"8","author":"Pagani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.xphs.2025.103954_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.124647","article-title":"Unravelling the stability and interaction site of ofloxacin in O\/W microemulsion by physicochemical characterization, NMR and cyclic voltammetry","volume":"402","author":"Mujahid","year":"2024","journal-title":"J Mol Liq"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0071","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1211\/0022357021017","article-title":"Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats","volume":"55","author":"Weso\u0142owska","year":"2010","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"10.1016\/j.xphs.2025.103954_bib0072","doi-asserted-by":"crossref","first-page":"117","DOI":"10.22270\/jddt.v13i10.5990","article-title":"Development and evaluation of microemulsion formualatons of Valsartan for solubility enhancement","volume":"13","author":"Kumari","year":"2023","journal-title":"J Drug Deliv Ther"},{"issue":"3-4","key":"10.1016\/j.xphs.2025.103954_bib0073","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/01932699108913128","article-title":"Behaviour of oil\/water microemulsions upon dilution with water","volume":"12","author":"Trotta","year":"1991","journal-title":"J Dispers Sci Technol"},{"issue":"9","key":"10.1016\/j.xphs.2025.103954_bib0074","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/10916466.2023.2232397","article-title":"Rheological behavior and microstructural properties of crude oil and emulsions (water\/oil-oil\/water)","volume":"42","author":"Yacine","year":"2024","journal-title":"Pet Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfa.2014.04.032","article-title":"Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug","volume":"455","author":"Chen","year":"2014","journal-title":"Colloids Surf A"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0076","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/jop.2013.0114","article-title":"Novel ofloxacin-loaded microemulsion formulations for ocular delivery","volume":"30","author":"\u00dcst\u00fcndag-Okur","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xphs.2025.103954_bib0077","doi-asserted-by":"crossref","DOI":"10.1038\/srep26895","article-title":"Formulation optimization of docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity","volume":"6","author":"Valicherla","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xphs.2025.103954_bib0078","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3109\/10717544.2014.993486","article-title":"Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design","volume":"23","author":"Kaur","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2025.103954_bib0079","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/358782","article-title":"Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity","volume":"2012","author":"Emami","year":"2012","journal-title":"J Nanomater"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0080","first-page":"8","article-title":"Development of a procedure for sterilizing filtration validation","author":"Vasilenko","year":"2022","journal-title":"Farm Delo Tehnol Lek (Pharm Pharm Technol)"},{"issue":"8","key":"10.1016\/j.xphs.2025.103954_bib0081","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.2042-7158.1956.tb12189.x","article-title":"The technique of sterility testing","volume":"8","author":"SYKES","year":"1956","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103954_bib0082","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-020-00515-3","article-title":"Science and risked-based stability testing strategies\u2014A Test case on the global implementation and regulatory reception","volume":"22","author":"Diaz","year":"2020","journal-title":"AAPS J"},{"issue":"23","key":"10.1016\/j.xphs.2025.103954_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The mtt assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0084","first-page":"1","article-title":"Avoiding the interference of doxorubicin with mtt measurements on the mcf-7 breast cancer cell line","volume":"2","author":"Luis","year":"2019","journal-title":"Methods Protoc"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1155\/1998\/842306","article-title":"Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology","volume":"17","author":"Ormerod","year":"1998","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.xphs.2025.103954_bib0086","doi-asserted-by":"crossref","unstructured":"Rahm\u00e9, R. (2021). Assaying cell cycle status using flow cytometry (pp. 165\u2013179). https:\/\/doi.org\/10.1007\/978-1-0716-1217-0_11.","DOI":"10.1007\/978-1-0716-1217-0_11"},{"key":"10.1016\/j.xphs.2025.103954_bib0087","series-title":"Encyclopedia of Life Sciences","article-title":"Cell cycle analysis by flow cytometry","author":"Darzynkiewicz","year":"2014"},{"key":"10.1016\/j.xphs.2025.103954_bib0088","series-title":"Paclitaxel","first-page":"73","article-title":"Application of nanocarriers for paclitaxel delivery and chemotherapy of cancer","author":"Malla","year":"2022"},{"key":"10.1016\/j.xphs.2025.103954_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119957","article-title":"Protective effects of hesperidin through attenuation of Ki67 expression against DMBA-induced breast cancer in female rats","volume":"285","author":"Patel","year":"2021","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0090","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1007\/s12253-020-00867-3","article-title":"Examination of tumor regression grading systems in breast cancer patients who received neoadjuvant therapy","volume":"26","author":"Sejben","year":"2020","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103954_bib0091","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xphs.2025.103954_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112376","article-title":"Novel doxorubicin \/folate-targeted trans-ferulic acid-loaded doxorubicin\/folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: in-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment","volume":"145","author":"Helmy","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2025.103954_bib0093","unstructured":"LiverTox: clinical and research information on drug-induced liver injury.; 2012."},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0094","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nano.2013.07.018","article-title":"A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel","volume":"10","author":"Jing","year":"2014","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.xphs.2025.103954_bib0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11094-021-02526-6","article-title":"Determination of paclitaxel solubility and stability in the presence of injectable excipients","volume":"55","author":"Sadeghi-Oroumiyeh","year":"2021","journal-title":"Pharm Chem J"},{"issue":"5","key":"10.1016\/j.xphs.2025.103954_bib0096","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10717540601098799","article-title":"Liposome formulation of paclitaxel with enhanced solubility and stability","volume":"14","author":"Yang","year":"2007","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0097","doi-asserted-by":"crossref","DOI":"10.4314\/just.v27i2.33039","article-title":"The modulation of haemolytic activity of non-ionic surfactants by oil-in-water microemulsions as vehicles for parental drug delivery","volume":"27","author":"Bayor","year":"2007","journal-title":"J Sci Technol (Ghana)"},{"issue":"23","key":"10.1016\/j.xphs.2025.103954_bib0098","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/1521-4095(200012)12:23<1751::AID-ADMA1751>3.0.CO;2-I","article-title":"Properties and applications of microemulsions","volume":"12","author":"Klier","year":"2000","journal-title":"Adv Mater"},{"key":"10.1016\/j.xphs.2025.103954_bib0099","article-title":"Parenteral microemulsions for drug delivery: advances and update","volume":"89","author":"Chavda","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10311-014-0466-2","article-title":"Surfactants: toxicity, remediation and green surfactants","volume":"12","author":"Rebello","year":"2014","journal-title":"Environ Chem Lett"},{"issue":"4","key":"10.1016\/j.xphs.2025.103954_bib0101","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.xphs.2021.12.002","article-title":"Emerging challenges and innovations in surfactant-mediated stabilization of biologic formulations","volume":"111","author":"Katz","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103954_bib0102","doi-asserted-by":"crossref","unstructured":"Rebello S, Asok AK, Mundayoor S, Jisha MS. Surfactants: chemistry, toxicity and remediation. In; 2013:277-320. doi:10.1007\/978-3-319-02387-8_5.","DOI":"10.1007\/978-3-319-02387-8_5"},{"issue":"2","key":"10.1016\/j.xphs.2025.103954_bib0103","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10876-021-02012-9","article-title":"A thermodynamic micellization and hemolysis evaluation of polysorbate surfactants in combination with short-chain alcohols","volume":"33","author":"Salarpour","year":"2022","journal-title":"J Clust Sci"},{"issue":"5","key":"10.1016\/j.xphs.2025.103954_bib0104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/138955712800493924","article-title":"Advances of Paclitaxel formulations based on nanosystem delivery technology","volume":"12","author":"Luo","year":"2012","journal-title":"Mini-Rev Med Chem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:49:41Z","timestamp":1779857381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022354925004083"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103954","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel cyclophosphamide microemulsion exhibits enhanced efficacy: Formulation development, evaluation, in-vitro cytotoxicity and in-vivo efficacy studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103954"}}